Our team at UNMC and Children's is proud to be a part of the TrialNet network. The TrialNet family is made up of physicians, scientists and healthcare teams at the forefront of type 1 diabetes research. We are also the largest international network of T1D researchers in the world.
We offer free Pathway to Prevention screening to relatives of people with T1D to detect the disease in its earliest stage—often years before symptoms appear. With the help of thousands of volunteers who are participating in our clinical studies, we are learning more and more about how T1D develops and testing new ways to maintain insulin production before and after diagnosis.